finasteride has been researched along with Polycystic Ovary Syndrome in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (26.67) | 18.2507 |
2000's | 10 (33.33) | 29.6817 |
2010's | 10 (33.33) | 24.3611 |
2020's | 2 (6.67) | 2.80 |
Authors | Studies |
---|---|
Brady, PH; Gin, GT; Rosenblum, E; Wilkinson, LD | 1 |
Asrar, MM; Bashir, R; Ganie, MA; Shah, IA; Wani, IA | 1 |
Azarchi, S; Bienenfeld, A; Lo Sicco, K; Marchbein, S; Nagler, AR; Shapiro, J | 1 |
Chapman, LW; Hu, AC; Mesinkovska, NA | 1 |
Check, JH; Cohen, R | 1 |
Karaca, Z; Kelestimur, F; Unluhizarci, K | 1 |
Alrasheed, H; Damiani, GR; De Pergola, G; De Salvia, MA; Loverro, G; Montagnani, M; Tartagni, M; Tartagni, MV | 1 |
Buzney, C; Buzney, E; Reynolds, RV; Sheu, J | 1 |
Fedorowicz, Z; van Zuuren, EJ | 1 |
Cicinelli, E; De Pergola, G; De Salvia, MA; Di Naro, E; Lavopa, C; Loverro, G; Tartagni, M | 1 |
Brodell, LA; Mercurio, MG | 1 |
Keller, DL | 1 |
Baracat, EC; de Lima, GR; Haidar, MA; Lakryc, EM; Motta, EL; Soares, JM | 1 |
Ajossa, S; Guerriero, S; Melis, GB; Orrù, M; Paoletti, AM | 1 |
Beigi, A; Sobhi, A; Zarrinkoub, F | 1 |
Ariê, WM; Bagnoli, VR; da Fonseca, AM | 1 |
Al-Inany, H | 2 |
Cirillo, D; Lombardi, G; Nappi, C; Petrone, A; Ronsini, S; Sarnacchiaro, F; Tolino, A | 1 |
Durmuşoğlu, F; Erenus, M | 1 |
De Fusco, D; Eleftheriou, G; Falsetti, L; Rosina, B | 1 |
De Fusco, D; Falsetti, L; Rosina, B | 1 |
Diamanti-Kandarakis, E | 1 |
Rittmaster, RS | 1 |
Bugari, G; Falsetti, L; Gambera, A; Iacobello, C; Legrenzi, L | 1 |
Caputo, M; Castello, R; Misciali, C; Moghetti, P; Muggeo, M; Negri, C; Perrone, F; Tosi, F; Tosti, A | 1 |
Civitillo, RM; D'Antò, V; Galante, L; Giannotti, F; Petrone, A; Rippa, G; Tolino, A | 1 |
Cicinelli, E; D'Addario, V; De Pergola, G; De Salvia, MA; Schonauer, LM; Tartagni, M | 1 |
Bayram, F; Güven, M; Müderris, II | 1 |
Mercurio, MG | 1 |
11 review(s) available for finasteride and Polycystic Ovary Syndrome
Article | Year |
---|---|
Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More than an Anti-androgen? Evidence from a Systematic Review and Meta-analysis.
Topics: Androgen Antagonists; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone | 2023 |
Androgens in women: Hormone-modulating therapies for skin disease.
Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Alopecia; Androgen Antagonists; Androgens; Contraceptives, Oral, Combined; Dutasteride; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Receptors, Androgen; Spironolactone | 2019 |
The efficacy and use of finasteride in women: a systematic review.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Dose-Response Relationship, Drug; Female; Finasteride; Hirsutism; Humans; Off-Label Use; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Teratogenesis; Time Factors; Treatment Outcome | 2019 |
Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Alopecia; Androgen Antagonists; Contraceptives, Oral, Combined; Dermatology; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Life Style; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Thiazolidinediones | 2014 |
Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Androgen Antagonists; Body Mass Index; Contraceptives, Oral; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Hypoglycemic Agents; Polycystic Ovary Syndrome; Quality of Life; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Spironolactone; Treatment Outcome; Young Adult | 2016 |
Hirsutism: Diagnosis and management.
Topics: 5-alpha Reductase Inhibitors; Adrenal Hyperplasia, Congenital; Causality; Contraceptives, Oral; Diagnosis, Differential; Eflornithine; Female; Finasteride; Hair Removal; Hirsutism; Humans; Hypoglycemic Agents; Laser Therapy; Metformin; Mineralocorticoid Receptor Antagonists; Neoplasms; Ornithine Decarboxylase Inhibitors; Polycystic Ovary Syndrome; Spironolactone | 2010 |
Polycystic ovary syndrome.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2005 |
How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
Topics: Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Flutamide; Humans; Polycystic Ovary Syndrome | 1998 |
Antiandrogen treatment of polycystic ovary syndrome.
Topics: Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone | 1999 |
Hirsutism: diagnosis and management.
Topics: Adrenal Hyperplasia, Congenital; Androgens; Contraceptives, Oral; Eflornithine; Enzyme Inhibitors; Female; Finasteride; Hair; Hirsutism; Humans; Medical History Taking; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone | 2001 |
12 trial(s) available for finasteride and Polycystic Ovary Syndrome
Article | Year |
---|---|
Intermittent low-dose finasteride administration is effective for treatment of hirsutism in adolescent girls: a pilot study.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Androstenediol; Dihydrotestosterone; Female; Finasteride; Glucuronides; Hirsutism; Humans; Patient Satisfaction; Pilot Projects; Polycystic Ovary Syndrome; Severity of Illness Index; Young Adult | 2014 |
Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women.
Topics: Adult; Double-Blind Method; Female; Finasteride; Humans; Hyperandrogenism; Ovulation Induction; Polycystic Ovary Syndrome; Young Adult | 2010 |
The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; 5-alpha Reductase Inhibitors; Adult; Androstenedione; Body Mass Index; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Double-Blind Method; Enzyme Inhibitors; Female; Finasteride; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Ovary; Placebos; Polycystic Ovary Syndrome; Prolactin; Testosterone; Ultrasonography | 2003 |
Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies | 2004 |
Effects of finasteride on the morphology of polycystic ovaries.
Topics: Adolescent; Adult; Double-Blind Method; Enzyme Inhibitors; Female; Finasteride; Humans; Polycystic Ovary Syndrome; Ultrasonography | 2004 |
Finasteride in the treatment of hirsutism: new therapeutic perspectives.
Topics: Adult; Androgens; Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Treatment Outcome | 1996 |
Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgen Antagonists; Androstenedione; Dehydroepiandrosterone Sulfate; Female; Finasteride; Flutamide; Hirsutism; Humans; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1997 |
[Finasteride and flutamide in the treatment of hirsutism].
Topics: Administration, Oral; Adult; Androgen Antagonists; Dose-Response Relationship, Drug; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome | 1997 |
Comparison of finasteride versus flutamide in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Enzyme Inhibitors; Female; Finasteride; Flutamide; Hirsutism; Hormones; Humans; Polycystic Ovary Syndrome | 1999 |
Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
Topics: Adult; Androgen Antagonists; Double-Blind Method; Female; Finasteride; Flutamide; Hair; Hirsutism; Hormones; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone | 2000 |
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Single-Blind Method; Treatment Outcome | 2000 |
A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism.
Topics: Adult; Androgen Antagonists; Body Mass Index; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin | 2000 |
7 other study(ies) available for finasteride and Polycystic Ovary Syndrome
Article | Year |
---|---|
Female Pelvic Conditions: Polycystic Ovary Syndrome.
Topics: Acne Vulgaris; Anovulation; Female; Finasteride; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Infertility; Letrozole; Male; Obesity; Polycystic Ovary Syndrome; Spironolactone; Weight Loss | 2022 |
Dihydrotestosterone may contribute to the development of migraine headaches.
Topics: 5-alpha Reductase Inhibitors; Contraceptives, Oral; Dextroamphetamine; Dihydrotestosterone; Female; Finasteride; Humans; Migraine Disorders; Polycystic Ovary Syndrome; Spironolactone; Young Adult | 2013 |
Hirsutism - from diagnosis to use of antiandrogens.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Spironolactone | 2013 |
Risks related to the use of finasteride (propecia) in pregnant women.
Topics: Contraindications; Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Pregnancy; Risk | 2010 |
The treatment of polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cabergoline; Cardiovascular Diseases; Clomiphene; Cyproterone Acetate; Diabetes Complications; Dopamine Agonists; Ergolines; Female; Finasteride; Flutamide; Follicle Stimulating Hormone; Gonadotropins; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Insulin Resistance; Metformin; Mineralocorticoid Receptor Antagonists; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Risk Factors; Spironolactone; Weight Loss | 2004 |
Efficacy and safety of finasteride?
Topics: Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; Patient Selection; Polycystic Ovary Syndrome; Reproducibility of Results; Testosterone; Ultrasonography | 1997 |
Usefulness of a 12-month treatment with finasteride in idiophathic and polycystic ovary syndrome-associated hirsutism.
Topics: Adolescent; Adult; Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Treatment Outcome | 1999 |